formance and accomplishments in 2010. I am very proud of the entire [Merisel] team for its continued effort and commitment to making our Company the high-performance organization it is today." Mr. Uzzi continued, "This is a most exciting time for our company as we reinvent and redefine our identity and positioning in the marketplace. As a result of our collective efforts, we have continued to gain momentum in 2011, and we remained focused on delivering new and innovative visual solutions to our clients to enhance and further build their brand equity."
Through forward-looking and innovative strategies, such as the creation of its VCMT (Visual Communications Management Trainee) Program, a first in the industry, and the launch of its Creative Services and Professional Services technology arms, Merisel continues to bolster its already-solid foundational capabilities.
"Simply, without underlying strengths, no organization can be 'turned around,'" further stated Mr. Uzzi. "Merisel, now doing business as Coloredge New York - Los Angeles, always possessed best-in-class professional qualities. By harnessing our capabilities, under a 'One Merisel' mandate, we not only restored this business to its rightful place, we accomplished something even more significant: at a time when many predicted the demise of manufacturing in the U.S., we have proven 'Made in America' is as vital today as ever, especially poignant when one considers our primary production facilities are in New York, New Jersey and Los Angeles."
Merisel released its first quarter 2011 results on May 16 highlighted by 15.7% growth in revenue for the quarter vs. last year, generating positive operating income for the fourth consecutive quarter, and will release second quarter earnings in mid-August. For more information please visit www.merisel.com and www.coPage: 1 2 3 4 5 Related biology technology :1
. Pressure BioSciences, Inc. to Discuss Second Quarter 2008 Financial Results and Provide Business Update2
. Pressure BioSciences, Inc. Reports Second Quarter 2008 Financial Results and Provides Business Update3
. Elanco Announces Acquisition of Posilac(R) Dairy Business4
. Sonus Pharmaceuticals and OncoGenex Technologies complete business combination; OncoGenex Pharmaceuticals to commence trading on NASDAQ Capital Market today5
. Chiltern Early Phase: Fully Integrated and Business Ready6
. Insulet Appoints Bill Arthur as Vice President of Business Development7
. Therapure Biopharma Inc. opens for business with first client contracts8
. Ohio Recognized as National Leader for Business Development and Job Creation9
. CBDM.T, The Market and Business Intelligence Company Reviews The Biomanufacturing Market10
. Cyberonics Provides Update on Business Operations Following Hurricane Ike11
. The Michigan Life Sciences Pipeline Announces New Best Practices Seminars Tailored to Michigan Businesses